Drug delivery system of hepatocyte growth factor for the treatment of vocal fold scarring in a canine model.

Abstract

OBJECTIVES:

Vocal fold scarring remains a therapeutic challenge. Previous studies have indicated that hepatocyte growth factor (HGF), a strong antifibrotic element, has therapeutic potential for restoring scarred vocal folds. To enhance the effect of HGF in vivo, we developed a novel drug delivery system (DDS) in which HGF is embedded in gelatin hydrogel and continuously released over a period of 2 weeks. In the present study we investigated the therapeutic efficacy of the HGF DDS on vocal fold scarring by using a canine model.

METHODS:

The vocal folds of 8 beagles were unilaterally scarred by stripping the entire layer of the lamina propria. The contralateral vocal folds were kept intact as normal controls. One month after the procedure, hydrogels (0.5 mL) containing 1 microg of HGF were injected into the scarred vocal folds of 4 dogs (HGF-treated group), whereas hydrogels containing saline solution were injected in the other 4 dogs (sham group). Histologic and vibratory examinations were completed for each group 6 months after the initial surgery.

RESULTS:

The excised larynx experiments showed significantly better vibration in terms of mucosal wave amplitude and glottal closure in the HGF-treated group compared to the sham group. Histologic evaluation of the vocal folds indicated remarkable reduction in collagen deposition and tissue contraction, with favorable restoration of hyaluronic acid and elastin in the HGF-treated group.

CONCLUSIONS:

The present findings suggest that the novel HGF DDS may provide favorable effects in restoring the vibratory properties of scarred vocal folds.

• Authors: Tsunehisa Ohno, Shigeru Hirano, Shin-ichi Kanemaru, Masaru Yamashita, Hiroo Umeda, Atsushi Suehiro, Yoshihiro Tamura, Tatsuo Nakamura, Juichi Ito, Yasuhiko Tabata
• Journal: The Annals of otology, rhinology, and laryngology (Ann Otol Rhinol Laryngol) Vol. 116 Issue 10 Pg. 762-9 (Oct 2007) ISSN: 0003-4894 [Print] United States
• PMID: 17987782 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)

Chemical References

• Hydrogel, Polyethylene Glycol Dimethacrylate
• Hepatocyte Growth Factor

Topics

• Animals
• Cicatrix (drug therapy, pathology)
• Disease Models, Animal
• Dogs
• Drug Delivery Systems (instrumentation)
• Hepatocyte Growth Factor (administration & dosage, therapeutic use)
• Hydrogel, Polyethylene Glycol Dimethacrylate
• Treatment Outcome
• Vocal Cords (pathology)